{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:10:53Z","timestamp":1793409053751,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This study was funded by the Scientific Research Fund of Education Department of Yunnan Province","award":["2025J0784"],"award-info":[{"award-number":["2025J0784"]}]},{"name":"This study was funded by the Scientific Research Fund of Education Department of Yunnan Province","award":["2025J0784"],"award-info":[{"award-number":["2025J0784"]}]},{"name":"This study was funded by the Scientific Research Fund of Education Department of Yunnan Province","award":["2025J0784"],"award-info":[{"award-number":["2025J0784"]}]},{"name":"This study was funded by the Scientific Research Fund of Education Department of Yunnan Province","award":["2025J0784"],"award-info":[{"award-number":["2025J0784"]}]},{"name":"This study was funded by the Scientific Research Fund of Education Department of Yunnan Province","award":["2025J0784"],"award-info":[{"award-number":["2025J0784"]}]},{"name":"This study was funded by the Scientific Research Fund of Education Department of Yunnan Province","award":["2025J0784"],"award-info":[{"award-number":["2025J0784"]}]},{"name":"This study was funded by the Scientific Research Fund of Education Department of Yunnan Province","award":["2025J0784"],"award-info":[{"award-number":["2025J0784"]}]},{"name":"This study was funded by the Scientific Research Fund of Education Department of Yunnan Province","award":["2025J0784"],"award-info":[{"award-number":["2025J0784"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lorazepam is extensively used to treat anxiety disorders and anxiety associated with depression. This study evaluates the safety of lorazepam based on real-world data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Data were collected from January 2004 to June 2024. After standardizing the data, we quantified signals using four algorithms, including the Reporting Odds Ratio (ROR), the Proportional Reporting Ratio (PRR), the Bayesian Confidence Propagation Neural Network (BCPNN), and the Multi-Item Gamma Poisson Shrinker (MGPS) to quantize the signal by Bayesian analysis and disproportionation analysis. AE signals were predominantly involved psychiatric disorders, nervous system disorders, injury, poisoning and procedural complications, and cardiac disorders. Notably, new potential AE signals of clinical value were identified in this study, including tachycardia, rhabdomyolysis, neologism, phagophobia, pancreatic fibrosis, and pneumonia. Sex-stratified analysis showed that the risk of poisoning was more pronounced in females and the AEs of sedation were more pronounced in males. Age-stratified analysis demonstrated variations in AEs across different age groups.The findings of this study were consistent with clinical trials, and identified several new potential AE signals. In addition, there are gender and age differences in some AEs. These findings provide valuable insights into lorazepam in clinical practice.<\/jats:p>","DOI":"10.1038\/s41598-025-05680-z","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T08:35:12Z","timestamp":1750754112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A real-world pharmacovigilance study of lorazepam based on the FDA adverse event reporting system database"],"prefix":"10.1038","volume":"15","author":[{"given":"Chunyue","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qionghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"5680_CR1","unstructured":"Ghiasi, N., Bhansali, R. K. & Marwaha, R. StatPearls (StatPearls Publishing LLC, 2024)."},{"key":"5680_CR2","doi-asserted-by":"publisher","first-page":"628965","DOI":"10.3389\/fpsyt.2021.628965","volume":"12","author":"M Amore","year":"2021","unstructured":"Amore, M., D\u2019Andrea, M. & Fagiolini, A. Treatment of agitation with lorazepam in clinical practice: A systematic review. Front. Psychiatry 12, 628965. https:\/\/doi.org\/10.3389\/fpsyt.2021.628965 (2021).","journal-title":"Front. Psychiatry"},{"key":"5680_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.schres.2024.07.004","volume":"270","author":"J Luccarelli","year":"2024","unstructured":"Luccarelli, J. et al. The effectiveness of the lorazepam challenge test in pediatric catatonia: A multisite retrospective cohort study. Schizophr Res. 270, 410\u2013415. https:\/\/doi.org\/10.1016\/j.schres.2024.07.004 (2024).","journal-title":"Schizophr Res."},{"key":"5680_CR4","doi-asserted-by":"publisher","unstructured":"\u00c7i\u00e7ek, S. S. Structure-dependent activity of natural GABA(A) receptor modulators. Molecules 23. https:\/\/doi.org\/10.3390\/molecules23071512 (2018).","DOI":"10.3390\/molecules23071512"},{"key":"5680_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-024-06672-z","author":"PM Baumert","year":"2024","unstructured":"Baumert, P. M. et al. Effects of lorazepam on saccadic eye movements\u2014evidence from prosaccade and free viewing tasks. Psychopharmacology. https:\/\/doi.org\/10.1007\/s00213-024-06672-z (2024).","journal-title":"Psychopharmacol. (Berl)"},{"key":"5680_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ecoenv.2017.12.049","volume":"150","author":"J Xiang","year":"2018","unstructured":"Xiang, J. et al. The fate and risk assessment of psychiatric pharmaceuticals from psychiatric hospital effluent. Ecotoxicol. Environ. Saf. 150, 289\u2013296. https:\/\/doi.org\/10.1016\/j.ecoenv.2017.12.049 (2018).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"5680_CR7","doi-asserted-by":"crossref","unstructured":"Zaman, H. et al. Benzodiazepines for psychosis-induced aggression or agitation. Cochrane Database Syst. Rev. 12 Cd003079 (2017).","DOI":"10.1002\/14651858.CD003079.pub4"},{"key":"5680_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.4140\/TCP.n.2017.610","volume":"32","author":"S Lam","year":"2017","unstructured":"Lam, S. & Macina, L. O. Therapy update for insomnia in the elderly. Consult. Pharm. 32, 610\u2013622. https:\/\/doi.org\/10.4140\/TCP.n.2017.610 (2017).","journal-title":"Consult Pharm."},{"key":"5680_CR9","first-page":"247","volume":"88","author":"MF Weaver","year":"2015","unstructured":"Weaver, M. F. Prescription sedative misuse and abuse. Yale J. Biol. Med. 88, 247\u2013256 (2015).","journal-title":"Yale J. Biol. Med."},{"key":"5680_CR10","doi-asserted-by":"publisher","first-page":"e11042","DOI":"10.7759\/cureus.11042","volume":"12","author":"T Gress","year":"2020","unstructured":"Gress, T., Miller, M., Meadows, C., 3rd & Neitch, S. M. Benzodiazepine overuse in elders: Defining the problem and potential solutions. Cureus 12, e11042. https:\/\/doi.org\/10.7759\/cureus.11042 (2020).","journal-title":"Cureus"},{"key":"5680_CR11","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jagp.2016.06.003","volume":"24","author":"RD Maree","year":"2016","unstructured":"Maree, R. D., Marcum, Z. A., Saghafi, E., Weiner, D. K. & Karp, J. F. A systematic review of opioid and benzodiazepine misuse in older adults. Am. J. Geriatr. Psychiatry 24, 949\u2013963. https:\/\/doi.org\/10.1016\/j.jagp.2016.06.003 (2016).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"5680_CR12","doi-asserted-by":"publisher","first-page":"1339721","DOI":"10.3389\/fphar.2024.1339721","volume":"15","author":"Y He","year":"2024","unstructured":"He, Y., Zhang, R., Shen, H. & Liu, Y. A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for denosumab. Front. Pharmacol. 15, 1339721. https:\/\/doi.org\/10.3389\/fphar.2024.1339721 (2024).","journal-title":"Front. Pharmacol."},{"key":"5680_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF03256796","volume":"24","author":"G Deshpande","year":"2010","unstructured":"Deshpande, G., Gogolak, V. & Smith, S. W. Data mining in drug safety: Review of published threshold criteria for defining signals of disproportionate reporting. Pharm. Med. 24, 37\u201343 (2010).","journal-title":"Pharm. Med."},{"key":"5680_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/pds.1107","volume":"14","author":"D Banks","year":"2005","unstructured":"Banks, D. et al. Comparing data mining methods on the VAERS database. Pharmacoepidemiol. Drug Saf. 14, 601\u2013609. https:\/\/doi.org\/10.1002\/pds.1107 (2005).","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"5680_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12991-023-00486-7","volume":"22","author":"S Li","year":"2023","unstructured":"Li, S. et al. Sex difference in incidence of major depressive disorder: An analysis from the global burden of disease study 2019. Ann. Gen. Psychiatry 22, 53. https:\/\/doi.org\/10.1186\/s12991-023-00486-7 (2023).","journal-title":"Ann. Gen. Psychiatry"},{"key":"5680_CR16","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/neurolint13040059","volume":"13","author":"AN Edinoff","year":"2021","unstructured":"Edinoff, A. N. et al. Benzodiazepines: Uses, dangers, and clinical considerations. Neurol. Int. 13, 594\u2013607. https:\/\/doi.org\/10.3390\/neurolint13040059 (2021).","journal-title":"Neurol. Int."},{"key":"5680_CR17","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.neuropharm.2010.10.020","volume":"60","author":"H M\u00f6hler","year":"2011","unstructured":"M\u00f6hler, H. The rise of a new GABA pharmacology. Neuropharmacology 60, 1042\u20131049. https:\/\/doi.org\/10.1016\/j.neuropharm.2010.10.020 (2011).","journal-title":"Neuropharmacology"},{"key":"5680_CR18","first-page":"90","volume":"22","author":"S Uzun","year":"2010","unstructured":"Uzun, S., Kozumplik, O., Jakovljevi\u0107, M. & Sedi\u0107, B. Side effects of treatment with benzodiazepines. Psychiatr. Danub. 22, 90\u201393 (2010).","journal-title":"Psychiatr Danub"},{"key":"5680_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4097\/kja.22078","volume":"75","author":"TJ Shin","year":"2022","unstructured":"Shin, T. J., Kim, P. J. & Choi, B. How general anesthetics work: From the perspective of reorganized connections within the brain. Korean J. Anesthesiol. 75, 124\u2013138. https:\/\/doi.org\/10.4097\/kja.22078 (2022).","journal-title":"Korean J. Anesthesiol"},{"key":"5680_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.addbeh.2005.04.024","volume":"31","author":"AJ Mol","year":"2006","unstructured":"Mol, A. J. et al. The absence of benzodiazepine craving in a general practice benzodiazepine discontinuation trial. Addict. Behav. 31, 211\u2013222. https:\/\/doi.org\/10.1016\/j.addbeh.2005.04.024 (2006).","journal-title":"Addict. Behav."},{"key":"5680_CR21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","volume":"21","author":"HU Wittchen","year":"2011","unstructured":"Wittchen, H. U. et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol. 21, 655\u2013679. https:\/\/doi.org\/10.1016\/j.euroneuro.2011.07.018 (2011).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"5680_CR22","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.2146\/ajhp160381","volume":"75","author":"JD Picton","year":"2018","unstructured":"Picton, J. D., Marino, A. B. & Nealy, K. L. Benzodiazepine use and cognitive decline in the elderly. Am. J. Health Syst. Pharm. 75, e6\u2013e12. https:\/\/doi.org\/10.2146\/ajhp160381 (2018).","journal-title":"Am. J. Health Syst. Pharm."},{"key":"5680_CR23","doi-asserted-by":"publisher","first-page":"121532","DOI":"10.1016\/j.lfs.2023.121532","volume":"320","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy, H. M. et al. Insights on benzodiazepines\u2019 potential in Alzheimer\u2019s disease. Life Sci. 320, 121532. https:\/\/doi.org\/10.1016\/j.lfs.2023.121532 (2023).","journal-title":"Life Sci."},{"key":"5680_CR24","first-page":"952","volume":"2","author":"N Kazemzadeh","year":"2014","unstructured":"Kazemzadeh, N., Mohammadi, S., Emamhadi, M., Amirfarhangi, A. & Sanaei-Zadeh, H. Electrocardiographic manifestations of benzodiazepine toxicity. Iran. J. Toxicol. 2, 952\u2013955 (2014).","journal-title":"Iran. J. Toxicol."},{"key":"5680_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/070674370505000315","volume":"50","author":"D Crockford","year":"2005","unstructured":"Crockford, D. & Re Lorazepam-induced prolongation of the QT interval in a patient with schizoaffective disorder and complete AV block. Can. J. Psychiatry 50, 184\u2013185. https:\/\/doi.org\/10.1177\/070674370505000315 (2005). author reply 185.","journal-title":"Can. J. Psychiatry"},{"key":"5680_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/0006-8993(88)90258-2","volume":"461","author":"K Kawasaki","year":"1988","unstructured":"Kawasaki, K., Matsushita, A., Satoh, M. & Takagi, H. The lateral vestibular nucleus is a site for the depressant action of benzodiazepines on the crossed extensor reflex. Brain Res. 461, 282\u2013289. https:\/\/doi.org\/10.1016\/0006-8993(88)90258-2 (1988).","journal-title":"Brain Res."},{"key":"5680_CR27","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/lary.1986.96.8.878","volume":"96","author":"SB Peppard","year":"1986","unstructured":"Peppard, S. B. Effect of drug therapy on compensation from vestibular injury. Laryngoscope 96, 878\u2013898. https:\/\/doi.org\/10.1002\/lary.1986.96.8.878 (1986).","journal-title":"Laryngoscope"},{"key":"5680_CR28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2165\/00003495-199550050-00002","volume":"50","author":"O Rascol","year":"1995","unstructured":"Rascol, O. et al. Antivertigo medications and drug-induced vertigo. A Pharmacological review. Drugs 50, 777\u2013791. https:\/\/doi.org\/10.2165\/00003495-199550050-00002 (1995).","journal-title":"Drugs"},{"key":"5680_CR29","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1158\/1078-0432.Ccr-23-0547","volume":"29","author":"AC Cornwell","year":"2023","unstructured":"Cornwell, A. C. et al. Lorazepam stimulates IL6 production and is associated with poor survival outcomes in pancreatic Cancer. Clin. Cancer Res. 29, 3793\u20133812. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-0547 (2023).","journal-title":"Clin. Cancer Res."},{"key":"5680_CR30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2165\/11533170-000000000-00000","volume":"24","author":"BE Smink","year":"2010","unstructured":"Smink, B. E., Egberts, A. C., Lusthof, K. J., Uges, D. R. & de Gier, J. J. The relationship between benzodiazepine use and traffic accidents: A systematic literature review. CNS Drugs  24, 639\u2013653. https:\/\/doi.org\/10.2165\/11533170-000000000-00000 (2010).","journal-title":"CNS Drugs"},{"key":"5680_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jneuroim.2015.04.001","volume":"282","author":"RD Sanders","year":"2015","unstructured":"Sanders, R. D. et al. Immune cell expression of GABAA receptors and the effects of diazepam on influenza infection. J. Neuroimmunol. 282, 97\u2013103. https:\/\/doi.org\/10.1016\/j.jneuroim.2015.04.001 (2015).","journal-title":"J. Neuroimmunol."},{"key":"5680_CR32","doi-asserted-by":"publisher","first-page":"e024180","DOI":"10.1136\/bmjopen-2018-024180","volume":"9","author":"SM Lin","year":"2019","unstructured":"Lin, S. M., Yang, S. H., Liang, C. C., Huang, H. K. & Loh, C. H. Association between benzodiazepine use and risks of chronic-onset poststroke pneumonia: A population-based cohort study. BMJ Open 9, e024180. https:\/\/doi.org\/10.1136\/bmjopen-2018-024180 (2019).","journal-title":"BMJ Open."},{"key":"5680_CR33","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s40263-024-01108-w","volume":"38","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Incident benzodiazepine and Z-Drug use and subsequent risk of serious infections. CNS Drugs 38, 827\u2013838. https:\/\/doi.org\/10.1007\/s40263-024-01108-w (2024).","journal-title":"CNS Drugs"},{"key":"5680_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cpr.2017.10.012","volume":"66","author":"RK McHugh","year":"2018","unstructured":"McHugh, R. K., Votaw, V. R., Sugarman, D. E. & Greenfield, S. F. Sex and gender differences in substance use disorders. Clin. Psychol. Rev. 66, 12\u201323. https:\/\/doi.org\/10.1016\/j.cpr.2017.10.012 (2018).","journal-title":"Clin. Psychol. Rev."},{"key":"5680_CR35","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.mayocp.2016.07.024","volume":"91","author":"M Markota","year":"2016","unstructured":"Markota, M., Rummans, T. A., Bostwick, J. M. & Lapid, M. I. Benzodiazepine use in older adults: Dangers, management, and alternative therapies. Mayo Clin. Proc. 91, 1632\u20131639. https:\/\/doi.org\/10.1016\/j.mayocp.2016.07.024 (2016).","journal-title":"Mayo Clin. Proc."},{"key":"5680_CR36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2174\/138920011796504473","volume":"12","author":"G Trifir\u00f2","year":"2011","unstructured":"Trifir\u00f2, G. & Spina, E. Age-related changes in pharmacodynamics: Focus on drugs acting on central nervous and cardiovascular systems. Curr. Drug Metab. 12, 611\u2013620. https:\/\/doi.org\/10.2174\/138920011796504473 (2011).","journal-title":"Curr. Drug Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05680-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05680-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05680-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T08:35:14Z","timestamp":1750754114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05680-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5680"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05680-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20272"}}